Developed by Bernard Attali and Asher Peretz, MD, of the Sackler Faculty of Medicine, the medication, known as BL-7050, inhibits the transmission of pain signals throughout the body. In experiments measuring electrical activity of neurons, the drug has been shown to prevent the hyper-excitability of neurons, protecting against neuropathic pain and epileptic seizures.

Related Articles on Pain Management:

Study Sheds Doubt on Steroid Injections for Back Pain
Wisconsin to Have Statewide Drug Monitoring System
Most Patients Take Incorrect Dosages of Prescription Drugs